Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

[Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico].

Ivancevich JC, Cardona V, Larenas-Linnemann D, Mullol J, Neffen H, Zernotti M, Asayag E, Blua AE, Gómez RM, Jares E, Máspero J, Anto JM, Dedeu T, Rodríguez-González M, Huerta-Villalobos YR, Fuentes-Pérez JM, Rodríguez-Zagal E, Valero A, Bartra J, Alobid I, Castillo-Vizuete JA, Dordal T, Hijano R, Picado C, Sastre J, Bedolla-Barajas M, Burguete-Cabañas MT, Costa-Domínguez MDC, Domínguez-Silva M, Espinoza-Contreras JG, Gálvez-Romero JL, García-Cobas CY, García-Cruz MLH, Hernández-Velázquez L, Luna-Pech JA, Matta JJ, Mogica-Martínez MD, Rivero-Yeverino D, Ruiz LT, Del Río-Navarro BE, Gómez-Vera J, Macías-Weinmann A, Agache I, Ansotegui I, Bachert C, Bedbrook A, Canonica GW, Casale TB, Cruz Á, Fokkens W, Hellings P, Samolinski B, Bousquet J.

Rev Alerg Mex. 2019 Oct-Dec;66(4):409-425. doi: 10.29262/ram.v66i4.643. Spanish.

PMID:
32105425
2.

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.

Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G.

Lancet Respir Med. 2020 Feb 14. pii: S2213-2600(19)30372-8. doi: 10.1016/S2213-2600(19)30372-8. [Epub ahead of print]

PMID:
32066536
3.

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial.

Menzies-Gow A, Corren J, Bel EH, Maspero J, Heaney LG, Gurnell M, Wessman P, Martin UJ, Siddiqui S, Garcia Gil E.

ERJ Open Res. 2019 Sep 25;5(3). pii: 00009-2019. doi: 10.1183/23120541.00009-2019. eCollection 2019 Jul.

4.

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.

Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP.

Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19. Erratum in: Lancet. 2019 Nov 2;394(10209):1618.

PMID:
31543428
5.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

Bousquet JJ, Schünemann HJ, Togias A, Erhola M, Hellings PW, Zuberbier T, Agache I, Ansotegui IJ, Anto JM, Bachert C, Becker S, Bedolla-Barajas M, Bewick M, Bosnic-Anticevich S, Bosse I, Boulet LP, Bourrez JM, Brusselle G, Chavannes N, Costa E, Cruz AA, Czarlewski W, Fokkens WJ, Fonseca JA, Gaga M, Haahtela T, Illario M, Klimek L, Kuna P, Kvedariene V, Le LTT, Larenas-Linnemann D, Laune D, Lourenço OM, Menditto E, Mullol J, Okamoto Y, Papadopoulos N, Pham-Thi N, Picard R, Pinnock H, Roche N, Roller-Wirnsberger RE, Rolland C, Samolinski B, Sheikh A, Toppila-Salmi S, Tsiligianni I, Valiulis A, Valovirta E, Vasankari T, Ventura MT, Walker S, Williams S, Akdis CA, Annesi-Maesano I, Arnavielhe S, Basagana X, Bateman E, Bedbrook A, Bennoor KS, Benveniste S, Bergmann KC, Bialek S, Billo N, Bindslev-Jensen C, Bjermer L, Blain H, Bonini M, Bonniaud P, Bouchard J, Briedis V, Brightling CE, Brozek J, Buhl R, Buonaiuto R, Canonica GW, Cardona V, Carriazo AM, Carr W, Cartier C, Casale T, Cecchi L, Cepeda Sarabia AM, Chkhartishvili E, Chu DK, Cingi C, Colgan E, de Sousa JC, Courbis AL, Custovic A, Cvetkosvki B, D'Amato G, da Silva J, Dantas C, Dokic D, Dauvilliers Y, Dedeu A, De Feo G, Devillier P, Di Capua S, Dykewickz M, Dubakiene R, Ebisawa M, El-Gamal Y, Eller E, Emuzyte R, Farrell J, Fink-Wagner A, Fiocchi A, Fontaine JF, Gemicioğlu B, Schmid-Grendelmeir P, Gamkrelidze A, Garcia-Aymerich J, Gomez M, González Diaz S, Gotua M, Guldemond NA, Guzmán MA, Hajjam J, O'B Hourihane J, Humbert M, Iaccarino G, Ierodiakonou D, Illario M, Ivancevich JC, Joos G, Jung KS, Jutel M, Kaidashev I, Kalayci O, Kardas P, Keil T, Khaitov M, Khaltaev N, Kleine-Tebbe J, Kowalski ML, Kritikos V, Kull I, Leonardini L, Lieberman P, Lipworth B, Lodrup Carlsen KC, Loureiro CC, Louis R, Mair A, Marien G, Mahboub B, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Maspero JF, Mathieu-Dupas E, Matricardi PM, Melén E, Melo-Gomes E, Meltzer EO, Menditto E, Mercier J, Miculinic N, Mihaltan F, Milenkovic B, Moda G, Mogica-Martinez MD, Mohammad Y, Montefort S, Monti R, Morais-Almeida M, Mösges R, Münter L, Muraro A, Murray R, Naclerio R, Napoli L, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Novellino E, Nyembue D, O'Hehir R, Ohta K, Okubo K, Onorato G, Ouedraogo S, Pali-Schöll I, Palkonen S, Panzner P, Park HS, Pépin JL, Pereira AM, Pfaar O, Paulino E, Phillips J, Picard R, Plavec D, Popov TA, Portejoie F, Price D, Prokopakis EP, Pugin B, Raciborski F, Rajabian-Söderlund R, Reitsma S, Rodo X, Romano A, Rosario N, Rottem M, Ryan D, Salimäki J, Sanchez-Borges MM, Sisul JC, Solé D, Somekh D, Sooronbaev T, Sova M, Spranger O, Stellato C, Stelmach R, Suppli Ulrik C, Thibaudon M, To T, Todo-Bom A, Tomazic PV, Valero AA, Valenta R, Valentin-Rostan M, van der Kleij R, Vandenplas O, Vezzani G, Viart F, Viegi G, Wallace D, Wagenmann M, Wang Y, Waserman S, Wickman M, Williams DM, Wong G, Wroczynski P, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zeng S, Zernotti M, Zhang L, Zhong NS, Zidarn M; ARIA Study Group; MASK Study Group.

Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019. Review.

6.

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.

Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, Peters AT, Pavord ID, Ford LB, Sher L, Rabe KF, Rice MS, Rowe P, Lu Y, Harel S, Jagerschmidt A, Khan AH, Kamat S, Pirozzi G, Amin N, Ruddy M, Graham NMH, Mannent LP, Teper A.

J Allergy Clin Immunol Pract. 2020 Feb;8(2):527-539.e9. doi: 10.1016/j.jaip.2019.07.016. Epub 2019 Jul 24.

7.

[MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries].

Larenas-Linnemann D, Mullol J, Ivancevich JC, Anto JM, Cardona V, Dedeu T, Rodríguez-González M, Huerta-Villalobos YR, Neffen H, Fuentes-Pérez JM, Rodríguez-Zagal E, Valero A, Zernotti M, Bartra J, Alobid I, Castillo-Vizuete JA, Dordal T, Hijano R, Picado C, Sastre J, Blua AE, Jares E, Lavrut AJ, Máspero J, Bedolla-Barajas M, Burguete-Cabañas MT, Costa-Domínguez MC, Domínguez-Silva M, Espinoza-Contreras JG, Gálvez-Romero JL, García-Cobas CY, García-Cruz MLH, Hernández-Velázquez L, Luna-Pech JA, Matta JJ, Mogica-Martínez MD, Rivero-Yeverino D, Ruiz LT, Del Río-Navarro BE, Gómez-Vera J, Macías-Weinmann A, Murray R, Onorato G, Laune D, Bedbrook A, Bousquet J.

Rev Alerg Mex. 2019 Apr-Jun;66(2):263-268. doi: 10.29262/ram.v66i2.628. Spanish.

PMID:
31200425
8.

[Environmental intervention in respiratory disease].

Ardusso LRF, Neffen HE, Fernández-Caldas E, Saranz RJ, Parisi CAS, Tolcachier A, Cicerán A, Smith S, Máspero JF, Nardacchione N, Marino D.

Medicina (B Aires). 2019;79(2):123-136. Review. Spanish.

9.

[MASK (Mobile Airways Sentinel Network). ARIA's comprehensive solution for mobile app for the multimorbidity of allergic rhinitis and asthma].

Larenas-Linnemann D, Mullol J, Ivancevich JC, Antó JM, Cardona V, Dedeu T, Rodríguez-González M, Huerta Y, Neffen H, Fuentes-Pérez JM, Rodríguez-Zagal E, Valero A, Zernotti M, Bartra J, Alobid I, Castillo-Vizuete JA, Dordal T, Hijano R, Picado C, Sastre J, Blua AE, Jares E, Lavrut AJ, Máspero J, Bedolla-Barajas M, Burguete M, Costa MC, Domínguez-Silva M, Espinoza-Contreras JG, Gálvez-Romero JL, García-Cobas CY, García-Cruz MLH, Hernández-Velázquez L, Luna-Pech J, Matta JJ, Mogica-Martínez MD, Rivero-Yeverino D, Ruiz-Segura LT, Del Río-Navarro B, Gómez J, Macías-Weinmann A, Murray R, Onorato G, Laune D, Bedbrook A, Bousquet J.

Rev Alerg Mex. 2019 Jan-Mar;66(1):140-146. doi: 10.29262/ram.v66i1.578. Spanish.

PMID:
31013416
10.

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.

Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H.

J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23.

11.

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A.

N Engl J Med. 2018 Jun 28;378(26):2475-2485. doi: 10.1056/NEJMoa1804093. Epub 2018 May 21.

12.

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.

Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A.

N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21.

13.

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma.

Busse WW, Maspero JF, Rabe KF, Papi A, Wenzel SE, Ford LB, Pavord ID, Zhang B, Staudinger H, Pirozzi G, Amin N, Akinlade B, Eckert L, Chao J, Graham NMH, Teper A.

Adv Ther. 2018 May;35(5):737-748. doi: 10.1007/s12325-018-0702-4. Epub 2018 May 3.

14.

[ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina].

Ivancevich JC, Neffen H, Zernotti ME, Asayag E, Blua A, Cicerán A, Jares EJ, Lavrut AJ, Máspero JF, Agache I, Bachert C, Bedbrook A, Canonica GW, Casale TB, Cruz ÁA, Fokkens WJ, Hellings PW, Samolinski B, Bousquet J.

Rev Alerg Mex. 2017 Jul-Sep;64(3):298-308. Spanish.

PMID:
29046028
15.
16.

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project).

Bousquet J, Agache I, Aliberti MR, Angles R, Annesi-Maesano I, Anto JM, Arnavielhe S, Asayag E, Bacci E, Bedbrook A, Bachert C, Baroni I, Barreto BA, Bedolla-Barajas M, Bergmann KC, Bertorello L, Bewick M, Bieber T, Birov S, Bindslev-Jensen C, Blua A, Bochenska Marciniak M, Bogus-Buczynska I, Bosnic-Anticevich S, Bosse I, Bourret R, Bucca C, Buonaiuto R, Burguete Cabanas MT, Caillaud D, Caimmi DP, Caiazza D, Camargos P, Canfora G, Cardona V, Carriazo AM, Cartier C, Castellano G, Chavannes NH, Cecci L, Ciaravolo MM, Cingi C, Ciceran A, Colas L, Colgan E, Coll J, Conforti D, Correia de Sousa J, Cortés-Grimaldo RM, Corti F, Costa E, Courbis AL, Cousein E, Cruz AA, Custovic A, Cvetkovski B, Dario C, da Silva J, Dauvilliers Y, De Blay F, Dedeu T, De Feo G, De Martino B, Demoly P, De Vries G, Di Capua Ercolano S, Di Carluccio N, Doulapsi M, Dray G, Dubakiene R, Eller E, Emuzyte R, Espinoza-Contreras JG, Estrada-Cardona A, Farrell J, Farsi A, Ferrero J, Fokkens WJ, Fonseca J, Fontaine JF, Forti S, Gálvez-Romero JL, García-Cobas CI, Garcia Cruz MH, Gemicioğlu B, Gerth van Wijk R, Guidacci M, Gómez-Vera J, Guldemond NA, Gutter Z, Haahtela T, Hajjam J, Hellings PW, Hernández-Velázquez L, Illario M, Ivancevich JC, Jares E, Joos G, Just J, Kalayci O, Kalyoncu AF, Karjalainen J, Keil T, Khaltaev N, Klimek L, Kritikos V, Kull I, Kuna P, Kvedariene V, Kolek V, Krzych-Fałta E, Kupczyk M, Lacwik P, La Grutta S, Larenas-Linnemann D, Laune D, Lauri D, Lavrut J, Lessa M, Levato G, Lewis L, Lieten I, Lipiec A, Louis R, Luna-Pech JA, Magnan A, Malva J, Maspero JF, Matta-Campos JJ, Mayora O, Medina-Ávalos MA, Melén E, Menditto E, Millot-Keurinck J, Moda G, Morais-Almeida M, Mösges R, Mota-Pinto A, Mullol J, Muraro A, Murray R, Noguès M, Nalin M, Napoli L, Neffen H, O'Hehir RE, Onorato GL, Palkonen S, Papadopoulos NG, Passalacqua G, Pépin JL, Pereira AM, Persico M, Pfaar O, Pozzi AC, Prokopakis E, Pugin B, Raciborski F, Rimmer J, Rizzo JA, Robalo-Cordeiro C, Rodríguez-González M, Rolla G, Roller-Wirnsberger RE, Romano A, Romano M, Romano MR, Salimäki J, Samolinski B, Serpa FS, Shamai S, Sierra M, Sova M, Sorlini M, Stellato C, Stelmach R, Strandberg T, Stroetmann V, Stukas R, Szylling A, Tan R, Tibaldi V, Todo-Bom A, Toppila-Salmi S, Tomazic P, Trama U, Triggiani M, Valero A, Valovirta E, Valiulis A, van Eerd M, Vasankari T, Vatrella A, Ventura MT, Verissimo MT, Viart F, Williams S, Wagenmann M, Wanscher C, Westman M, Wickman M, Young I, Yorgancioglu A, Zernotti E, Zuberbier T, Zurkuhlen A, De Oliviera B, Senn A.

Allergy. 2018 Jan;73(1):77-92. doi: 10.1111/all.13218. Epub 2017 Aug 24.

17.

Similar biological activity in skin prick test for Oralair® (8200 BAU) and Grazax® (6200 BAU) reinforces effective SLIT dosing level.

Larenas Linnemann DE, Singh J, Rosario N, Esch R, Matta JJ, Maspero J, Michels A, Mösges R.

Allergy. 2016 Dec;71(12):1782-1786. doi: 10.1111/all.12998. Epub 2016 Sep 12.

PMID:
27484017
18.

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.

Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, Pirozzi G, Sutherland ER, Evans RR, Joish VN, Eckert L, Graham NM, Stahl N, Yancopoulos GD, Louis-Tisserand M, Teper A.

Lancet. 2016 Jul 2;388(10039):31-44. doi: 10.1016/S0140-6736(16)30307-5. Epub 2016 Apr 27.

PMID:
27130691
19.

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.

Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M.

Chest. 2016 Oct;150(4):789-798. doi: 10.1016/j.chest.2016.03.032. Epub 2016 Apr 4.

20.

Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States.

Nathan RA, Thompson PJ, Price D, Fabbri LM, Salvi S, González-Díaz S, Maspero JF, Moreno-Cantu JJ, Fish JE, Murphy K.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):734-42.e5. doi: 10.1016/j.jaip.2015.04.013. Epub 2015 Jun 23.

PMID:
26116167
21.

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.

Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O'Brien C, Korn S.

Lancet Respir Med. 2015 May;3(5):355-66. doi: 10.1016/S2213-2600(15)00042-9. Epub 2015 Feb 23. Erratum in: Lancet Respir Med. 2015 Apr;3(4):e15. Lancet Respir Med. 2016 Oct;4(10 ):e50.

PMID:
25736990
22.

[Argentine guidelines for urticaria and angioedema].

Máspero J, Cabrera H, Ardusso L, De Gennaro M, Fernández Bussy R, Galimany J, Galimberti D, Label M, La Forgia M, Medina I, Neffen H, Troielli P; Asociación Argentina de Alergia e Inmunología Clínica (AAAeIC); Sociedad Argentina de Dermatología.

Medicina (B Aires). 2014;74 Suppl 1:1-53. Spanish.

23.

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

Maspero J, Cherrez I, Doherty DE, Tashkin DP, Kuna P, Kuo WL, Gates D, Nolte H, Chylack LT Jr.

Respir Med. 2014 Sep;108(9):1355-62. doi: 10.1016/j.rmed.2014.04.015. Epub 2014 May 2.

24.

Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis.

Lee LA, Sterling R, Máspero J, Clements D, Ellsworth A, Pedersen S.

J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):421-7. doi: 10.1016/j.jaip.2014.04.008. Epub 2014 May 21.

PMID:
25017530
25.

Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma.

Maspero J, Backer V, Yao R, Staudinger H, Teper A.

J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):649-55.e1. doi: 10.1016/j.jaip.2013.07.011. Epub 2013 Oct 8.

PMID:
24565713
26.

Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America.

Maspero JF, Jardim JR, Aranda A, Tassinari C P, Gonzalez-Diaz SN, Sansores RH, Moreno-Cantu JJ, Fish JE.

World Allergy Organ J. 2013 Nov 4;6(1):19. doi: 10.1186/1939-4551-6-19.

27.

Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.

Potter P, Maspero JF, Vermeulen J, Barkai L, Németh I, Baillieau RA, Garde JM, Giralt J, Doménech A, Izquierdo I, Nieto A.

Pediatr Allergy Immunol. 2013 Mar;24(2):144-50. doi: 10.1111/pai.12036. Epub 2013 Feb 6.

PMID:
23384091
28.

Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy.

Parisi CA, Smaldini PL, Gervasoni ME, Maspero JF, Docena GH.

Clin Exp Allergy. 2013 Feb;43(2):249-54. doi: 10.1111/cea.12059.

PMID:
23331566
29.

Quality of life and control of allergic rhinitis in patients from regions beyond western Europe and the United States.

Maspero J, Lee BW, Katelaris CH, Potter PC, Cingi C, Lopatin A, Saffer M, Nadeau G, Walters RD.

Clin Exp Allergy. 2012 Dec;42(12):1684-96. doi: 10.1111/j.1365-2222.2012.04025.x. Review.

PMID:
23181786
30.

[Poorly controlled asthma: diagnosis and therapeutics in children and adolescents].

Neffen H, Vidaurreta S, Balanzat A, De Gennaro MS, Giubergia V, Maspero JF, Saranz RJ, Teper AM.

Medicina (B Aires). 2012;72(5):403-13. Review. Spanish.

31.

Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America.

Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A, Saffer M, Xu G, Walters RD.

Clin Exp Allergy. 2012 Feb;42(2):186-207. doi: 10.1111/j.1365-2222.2011.03891.x. Epub 2011 Nov 3. Review.

PMID:
22092947
32.

Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma.

Bachert C, Maspero J.

J Asthma. 2011 Nov;48(9):965-73. doi: 10.3109/02770903.2011.616616. Epub 2011 Oct 4. Review.

PMID:
21970671
33.

Components of asthma control and treatment response of individual control criteria in children: analysis of the PEACE study.

Pedersen S, Maspero J, Gul N, Sharma R.

Pediatr Pulmonol. 2011 Dec;46(12):1182-8. doi: 10.1002/ppul.21499. Epub 2011 Jul 12.

PMID:
21751432
34.

An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.

Maspero JF, Walters RD, Wu W, Philpot EE, Naclerio RM, Fokkens WJ.

Allergy Asthma Proc. 2010 Nov-Dec;31(6):483-92. doi: 10.2500/aap.2010.31.3397.

PMID:
21708060
35.

Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.

Maspero JF, Nolte H, Chérrez-Ojeda I; P04139 Study Group.

J Asthma. 2010 Dec;47(10):1106-15. doi: 10.3109/02770903.2010.514634. Epub 2010 Nov 1. Erratum in: J Asthma. 2011 Feb;48(1):114.

36.

[Allergen immunotherapy for prevention and treatment of respiratory allergy in childhood].

Comité Nacional de Alergia de la Sociedad Argentina de Pediatría, Saranz RJ, Lozano A, Cáceres ME, Arnolt RG, Máspero JF, Bozzola CM, Neffen HE, Croce VH, Gualtier O, Procopio N.

Arch Argent Pediatr. 2010 Jun;108(3):258-65. doi: 10.1590/S0325-00752010000300020. Spanish. No abstract available.

38.

[Chronic autoimmune urticaria: treatment with omalizumab].

Máspero JF, Parisi CA, De Gennaro M, Benhabib O, Lampert M.

Arch Argent Pediatr. 2009 Oct;107(5):452-6. doi: 10.1590/S0325-00752009000500014. Spanish.

39.
40.

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504. doi: 10.1016/j.clinthera.2008.07.018.

PMID:
18803991
41.

A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.

Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I; international Rupatadine study group.

Allergy. 2008 Jul;63(7):924-31. doi: 10.1111/j.1398-9995.2008.01668.x.

PMID:
18588560
42.

Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organization.

Kaliner MA, Del Giacco S, Crisci CD, Frew AJ, Liu G, Maspero J, Moon HB, Nakagawa T, Potter PC, Rosenwasser LJ, Singh AB, Valovirta E, Van Cauwenberge P, Warner JO; WAO Specialty and Training Council.

World Allergy Organ J. 2008 Feb;1(2):42-6. doi: 10.1097/WOX.0b013e3181651689. No abstract available.

43.

Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis.

Máspero JF, Rosenblut A, Finn A Jr, Lim J, Wu W, Philpot E.

Otolaryngol Head Neck Surg. 2008 Jan;138(1):30-7. doi: 10.1016/j.otohns.2007.10.023.

PMID:
18164990
44.

What is an Allergist?: Reconciled Document Incorporating Member Society Comments, September 3, 2007.

Del Giacco S, Rosenwasser LJ, Crisci CD, Frew AJ, Kaliner MA, Lee BW, Guanghui L, Maspero J, Moon HB, Takemasa N, Potter PC, Singh AB, Valovirta E, Vervloet D, Warner JO, Henley K; position statement of the WAO Specialty and Training Council:.

World Allergy Organ J. 2008 Jan;1(1):19-20. doi: 10.1097/wox.0b013e3181651679. No abstract available.

45.

Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma.

Skoner DP, Maspero J, Banerji D; Ciclesonide Pediatric Growth Study Group.

Pediatrics. 2008 Jan;121(1):e1-14. Epub 2007 Dec 10.

PMID:
18070931
46.

Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.

Qaqundah PY, Sugerman RW, Ceruti E, Maspero JF, Kleha JF, Scott CA, Wu W, Mehta R, Crim C.

J Pediatr. 2006 Nov;149(5):663-670. Erratum in: J Pediatr. 2007 May;150(5):565.

PMID:
17095339
47.

Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council.

Warner JO, Kaliner MA, Crisci CD, Del Giacco S, Frew AJ, Liu GH, Maspero J, Moon HB, Nakagawa T, Potter PC, Rosenwasser LJ, Singh AB, Valovirta E, Van Cauwenberge P; World Allergy Organization Specialty and Training Council.

Int Arch Allergy Immunol. 2006;139(2):166-74. Epub 2005 Dec 23. Review.

PMID:
16388197
48.
49.

[Nasosinus repercussions of hemopathies].

Maspero JC, Roffo LM.

Arch Argent Pediatr. 1969 Jan-Jun;67(1):37-8. Spanish. No abstract available.

PMID:
5396761

Supplemental Content

Loading ...
Support Center